Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Cordis Corporation clinical trials
The registry lists 78 studies whose lead sponsor is Cordis Corporation. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 2, 2026.
Keep track of what changes. Save the Cordis Corporation studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesRegistry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Cordis Corporation.
- Cordis Corporation70 studiesSame company
Something wrong?
- Cordis US Corp.8 studiesSame company
Something wrong?
Focus areas
Conditions Cordis Corporation leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 50 of 78. Browse all 78 →
- Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery StenosisRecruitingNCT07122518
Sponsor listed in the registry: Cordis US Corp.
- Post-Market Clinical Follow-Up of S.M.A.R.T. Family of Stents in Treating Iliac and Femoropopliteal Artery DiseaseNot yet recruitingNCT07338890
Sponsor listed in the registry: Cordis US Corp.
- Mobilization and Outcomes After Venous ClosureCompletedNCT07246902
Sponsor listed in the registry: Cordis US Corp.
- Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure DeviceCompletedNCT03923387Not applicable
Sponsor listed in the registry: Cordis US Corp.
- PMCF Study of Precise Pro Rx for Carotid Artery DiseaseCompletedNCT07204678
Sponsor listed in the registry: Cordis US Corp.
- Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial AccessCompletedNCT05399680Not applicable
Sponsor listed in the registry: Cordis US Corp.
- Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual CompressionCompletedNCT05554471Not applicable
- A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft® Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INSPIRATION)CompletedNCT01664078Not applicable
Sponsor listed in the registry: Cordis US Corp.
- European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic AneurysmsCompletedNCT02477111
Sponsor listed in the registry: Cordis US Corp.
- PMCF Study for Cardiology Access ProceduresCompletedNCT05543096
- PMCF Study for Peripheral Arteries Above the Knee (ATK)CompletedNCT05312580
- PMCF Study for Peripheral Arteries Below the Knee (BTK)CompletedNCT05444660
- A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)CompletedNCT01106391Not applicable
- China Post-market Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms (INITIATION)WithdrawnNCT03965364
- SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for EndarterectomyCompletedNCT00403078
- Compassionate Use of the Incraft® AAA Stent Graft SystemNo longer availableNCT01776450
- Evaluation of Safety and Efficacy of the FlexStent® Femoropopliteal Self-Expanding Stent SystemCompletedNCT01355406Not applicable
- S.M.A.R.T.® Nitinol Self-Expandable Stent in the Treatment of Obstructive Superficial Femoral Artery DiseaseCompletedNCT00739102Not applicable
- CYPRESS - CYPHER for Evaluating Sustained SafetyStatus unknownNCT00954707Phase 4
- Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent SystemsStatus unknownNCT00715884Not applicable
- A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)CompletedNCT00322569Phase 3
- An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)TerminatedNCT01202058Phase 3
- Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery LesionsTerminatedNCT00714883Phase 2
- Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery LesionsTerminatedNCT00606333Not applicable
- Safety and Effectiveness Study of the Ensure Medical Vascular Closure DeviceCompletedNCT00345631Phase 3
- ECLIPSE Feasibility Trial (Ensure's Vascular Closure Device Speeds Hemostasis Trial) EUCompletedNCT00574691Phase 1
- Plug Arterial Closure System (PACS, 7F)CompletedNCT00533156Phase 2
- Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)CompletedNCT00165035Phase 3
- Cynergy: the CYPHER-NEVO RegistryTerminatedNCT01106378
- Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial DiseaseCompletedNCT00640770Phase 4
- French Post-Marketing Surveillance SurveyTerminatedNCT00855478Phase 4
- The Intra-Drug Eluting Stent (DES) Restenosis StudyCompletedNCT00323895Phase 4
- A Study of the Presillion Stent in de Novo Coronary LesionsCompletedNCT00722579Phase 3
- The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)CompletedNCT00974181Phase 3
- NEXUS Study for the Treatment of de Novo Native Coronary Artery LesionsCompletedNCT00231283Phase 3
- Study of the 2.25mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232739Phase 3
- The Study to Compare the Cordis SMART™ Stent System With the Bard® Luminexx™ StentCompletedNCT00235131Phase 4
- Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialCompletedNCT00497172Phase 4
- The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.CompletedNCT00749424Phase 4
- A Study of the SMART Stent in the Treatment SFA Disease.CompletedNCT00232869Phase 2
- Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry (SECURE)CompletedNCT00231244Phase 3
- A Multi-center Post-Market Surveillance RegistryCompletedNCT00438919Phase 4
- A Study of Diabetic Patients With De Novo Native Coronary Artery LesionsCompletedNCT00495898Phase 4
- Study of the 4.0mm Sirolimus-Eluting Stent in the Treatment of Patients With Coronary Artery LesionsCompletedNCT00232752Phase 3
- Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)CompletedNCT00231257Phase 3
- Double or Single Dose Sirolimus-Eluting Stents in Diabetic Patients With de Novo Coronary Artery LesionsCompletedNCT00233714Phase 1/2
- The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)CompletedNCT00403338
- Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)CompletedNCT00232765Phase 3
- The Study to Assess AMI Treated With Balloon Angioplasty.CompletedNCT00232830Phase 3
- The Study to Compare SMART Nitinol Stent and Balloon AngioplastyCompletedNCT00309595Phase 4